<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01277861</url>
  </required_header>
  <id_info>
    <org_study_id>092010-013</org_study_id>
    <nct_id>NCT01277861</nct_id>
  </id_info>
  <brief_title>Airway Responses During Desflurane Anesthesia Via a Laryngeal Mask Airway: Effects of Fentanyl Pretreatment</brief_title>
  <official_title>Airway Responses During Desflurane Anesthesia Via a Laryngeal Mask Airway: Effects of Fentanyl Pretreatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators plan to test the hypothesis that pretreatment with fentanyl prior to
      induction of anesthesia would result in reduce the incidence of movements and airway
      responses to desflurane in patients breathing spontaneously through a laryngeal mask airway
      (LMA). The primary aim of this study is to assess the effect of fentanyl pretreatment on the
      incidence of movement during induction of anesthesia. Secondary aim of the study is to
      evaluate the effects of titration of fentanyl according to the respiratory rate on the
      incidence of intraoperative respiratory events such as coughing, breath holding and
      laryngospasm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After obtaining approval from the institutional review board and informed consent, 100
      patients, 18-64 years of age, scheduled for elective superficial and peripheral surgery of
      less than 2 h duration would be enrolled in this prospective, randomized, double-blind,
      placebo-controlled study. Patients will be randomly assigned to one of two anesthetic
      techniques according to a computer-generated random numbers table. Patients will receive
      either fentanyl or saline prior to induction of anesthesia, while the rest of the anesthetic
      and analgesic technique will be standardized for all patients.

      Exclusion criteria will include obesity (body mass index &gt;30), pregnancy, history of
      gastroesophageal reflux, hiatal hernia, significant cardiovascular, pulmonary (e.g., reactive
      airway disease), hepatic, renal, neurologic, metabolic, and endocrine disease as well as
      history of alcohol and drug abuse as well as those requiring tracheal intubation.

      After premedication with midazolam 2 mg, patients will be transferred to the operating room.
      On arrival in the operating room standard monitors and the BIS (BiSpectral Index)monitor will
      be applied. Patients will then be preoxygenated for 2-3 minutes with 100% oxygen, which will
      be followed by administration of either fentanyl 1 µg/kg (made up to 10 ml saline) or 10 ml
      saline (prepared by a person not involved in the study). Induction of anesthesia will be
      performed 2-3 minutes after administration of the study drug with propofol 2.0 - 2.5 mg/kg
      after lidocaine 2% 20-30 mg. After loss of eyelash reflex an appropriate size LMA will be
      placed. If the patients become apneic, manual ventilation will be performed with
      oxygen/nitrous oxide and desflurane, 3% dialed concentration initially and then titrated to
      maintain the BIS value of 50-60.

      Anesthesia will be maintained with desflurane titrated to achieve a BIS value of 50-60, along
      with 50% nitrous oxide and oxygen. Once spontaneous breathing resumes, fentanyl 25-50 µg will
      be administered to achieve a respiratory rate of 10-15 breaths/minute. Additional
      propofol/fentanyl will be administered, if deemed necessary by the attending
      anesthesiologist. All patients will receive dexamethasone 4 mg, IV after induction of
      anesthesia and ondansetron 4 mg 20-30 minutes prior to the end of surgery. Desflurane will be
      discontinued after closure of the surgical wound.

      A blinded observer will record patient demographics (age, weight, height) and history of
      smoking from preoperative evaluation. Data collected during the intraoperative period will
      include need for manual ventilation and duration of manual ventilation, duration of
      anesthesia, total doses of propofol and fentanyl, and time from discontinuation of desflurane
      until patient first follows verbal command as well as heart rate (HR), mean arterial blood
      pressure (MAP), end-tidal carbon dioxide, oxygen saturation, and end-tidal gas concentration
      will be recorded every 15 minutes.

      Data collected in the postoperative period will include verbal rating score (0 to 10) will be
      used to assess pain, nausea, and vomiting in the recovery room every 15 minutes for one hour
      as well as the need for rescue medications will also be recorded.

      Patients will also be contacted approximately 24 hours after surgery to evaluate their post
      operative course including occurrence of any adverse events. The patient will remain in the
      study for approximately 24 hours.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Movement</measure>
    <time_frame>Induction of Anesthesia</time_frame>
    <description>The data provided below include participants who moved (includes all grades of movement ie, mild, moderate and severe).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Apnea</measure>
    <time_frame>Induction of Anesthesia</time_frame>
    <description>Apnea defined as no breathing for at least 30 s.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coughing</measure>
    <time_frame>Intraoperative period</time_frame>
    <description>Data include patients who coughed irrespective of the degree of coughing.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Administration Site Reaction</condition>
  <arm_group>
    <arm_group_label>FENTANYL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>FENTANYL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SALINE</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>SALINE</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>FENTANYL PRETREATMENT DURING INDUCTION OF ANESTHESIA</description>
    <arm_group_label>FENTANYL</arm_group_label>
    <arm_group_label>SALINE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-64 years of age

          -  Subjects scheduled for elective superficial and peripheral surgery of less than 2 h
             duration (e.g., hernia surgery, breast surgery, upper or lower limb surgery,
             superficial abdominal/chest wall surgery [i.e., lipoma], minor gynecological
             procedures [i.e., hysteroscopy])

        Exclusion Criteria:

          -  obesity (body mass index &gt;30)

          -  pregnancy

          -  history of gastroesophageal reflux, hiatal hernia, significant cardiovascular,
             pulmonary (e.g., reactive airway disease), hepatic, renal, neurologic, metabolic, and
             endocrine disease

          -  history of alcohol and drug abuse

          -  requiring tracheal intubation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Girish P Joshi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Southwestern Medical Center, Dallas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ut Southwestern Medical Center At Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2010</study_first_submitted>
  <study_first_submitted_qc>January 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 17, 2011</study_first_posted>
  <results_first_submitted>February 16, 2012</results_first_submitted>
  <results_first_submitted_qc>March 14, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 15, 2013</results_first_posted>
  <last_update_submitted>March 14, 2013</last_update_submitted>
  <last_update_submitted_qc>March 14, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 15, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>Girish P Joshi, MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Desflurane, Fentanyl, Airway responses</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were recruited for the study in the preoperative period.</recruitment_details>
      <pre_assignment_details>Participants were included based on inclusion/exclusion criteria. Participants were excluded if muscle relaxation was necessary for the surgery.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>FENTANYL</title>
          <description>FENTANYL</description>
        </group>
        <group group_id="P2">
          <title>SALINE</title>
          <description>SALINE</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>FENTANYL</title>
          <description>FENTANYL</description>
        </group>
        <group group_id="B2">
          <title>SALINE</title>
          <description>SALINE</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="49"/>
            <count group_id="B2" value="47"/>
            <count group_id="B3" value="96"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <description>Body mass index is calculated from height and weight of the patient.</description>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.8" spread="4.3"/>
                    <measurement group_id="B2" value="26.8" spread="4.7"/>
                    <measurement group_id="B3" value="26.8" spread="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Movement</title>
        <description>The data provided below include participants who moved (includes all grades of movement ie, mild, moderate and severe).</description>
        <time_frame>Induction of Anesthesia</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Fentanyl Pretreatment Group</title>
            <description>Fentanyl 1 µg/kg (constituted to 10 ml with saline) prior to induction of anesthesia.</description>
          </group>
          <group group_id="O2">
            <title>Saline Pretreatment Group</title>
            <description>Saline 10 ml prior to induction of anesthesia.</description>
          </group>
        </group_list>
        <measure>
          <title>Movement</title>
          <description>The data provided below include participants who moved (includes all grades of movement ie, mild, moderate and severe).</description>
          <population>Per protocol</population>
          <units>Participants, number</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Apnea</title>
        <description>Apnea defined as no breathing for at least 30 s.</description>
        <time_frame>Induction of Anesthesia</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Fentanyl Pretreatment Group</title>
          </group>
          <group group_id="O2">
            <title>Saline Pretreatment Group</title>
          </group>
        </group_list>
        <measure>
          <title>Apnea</title>
          <description>Apnea defined as no breathing for at least 30 s.</description>
          <population>Per protocol</population>
          <units>Participants, number</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Coughing</title>
        <description>Data include patients who coughed irrespective of the degree of coughing.</description>
        <time_frame>Intraoperative period</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Fentanyl Pretreatment Group</title>
            <description>Fentanyl 1 µg/kg (constituted to 10 ml with saline) prior to induction of anesthesia.</description>
          </group>
          <group group_id="O2">
            <title>Saline Pretreatment Group</title>
            <description>Saline 10 ml prior to induction of anesthesia.</description>
          </group>
        </group_list>
        <measure>
          <title>Coughing</title>
          <description>Data include patients who coughed irrespective of the degree of coughing.</description>
          <population>Per protocol</population>
          <units>Participants, number</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Patients were followed for up to 24 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>FENTANYL</title>
          <description>FENTANYL</description>
        </group>
        <group group_id="E2">
          <title>SALINE</title>
          <description>SALINE</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="47"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="47"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Girish P. Joshi, MD</name_or_title>
      <organization>University of Texas Southwestern Medical Center at Dallas</organization>
      <phone>214-590-7259</phone>
      <email>girish.joshi@utsouthwestern.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

